Cosmos Health to Launch Patented Liver Fat Reduction Supplement Liv18 in US by Q2 2026

Cosmos Health has announced plans to expand its presence in the United States with the upcoming launch of Liv18, a patented dietary supplement designed to reduce liver fat. The company confirmed that Liv18 will be introduced during the second quarter of 2026. According to Cosmos Health, the supplement is clinically proven and aims to address issues related to liver health, specifically targeting fatty liver conditions.

The product is based on proprietary research and features a patented formula developed by Cosmos Health. The company states that Liv18 underwent clinical testing, which demonstrated its effectiveness in reducing liver fat. This launch marks another step in Cosmos Health’s strategy to broaden its footprint within the U.S. market while addressing growing consumer demand for health-focused supplements. Further details regarding distribution channels or pricing have not yet been disclosed.

Newsflash | Powered by GeneOnline AI

Source: GO-AI-ne1

For any suggestion and feedback, please contact us.

Date: April 8, 2026

Author

GOAI